Cargando…

Symptomatic and Asymptomatic Patients in the Polish Atrial Fibrillation (POL-AF) Registry

Background: Atrial fibrillation (AF) can cause severe symptoms, but it is frequently asymptomatic. We aimed to compare the clinical features of patients with asymptomatic and symptomatic AF. Methods: A prospective, observational, multicenter study was performed (the Polish Atrial Fibrillation (POL-A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiliszek, Marek, Uziębło-Życzkowska, Beata, Gorczyca, Iwona, Maciorowska, Małgorzata, Jelonek, Olga, Wożakowska-Kapłon, Beata, Wójcik, Maciej, Błaszczyk, Robert, Gawałko, Monika, Kapłon-Cieślicka, Agnieszka, Tokarek, Tomasz, Rajtar-Salwa, Renata, Bil, Jacek, Wojewódzki, Michał, Szpotowicz, Anna, Krzciuk, Małgorzata, Bednarski, Janusz, Bakuła-Ostalska, Elwira, Tomaszuk-Kazberuk, Anna, Szyszkowska, Anna, Wełnicki, Marcin, Mamcarz, Artur, Krzesiński, Paweł
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961425/ https://www.ncbi.nlm.nih.gov/pubmed/33807883 http://dx.doi.org/10.3390/jcm10051091

Ejemplares similares

Hyperuricemia as a Marker of Reduced Left Ventricular Ejection Fraction in Patients with Atrial Fibrillation: Results of the POL-AF Registry Study
por: Wełnicki, Marcin, et al.
Publicado: (2021)

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Szpotowicz, Anna, et al.
Publicado: (2021)

Association of Hyperuricemia with Impaired Left Ventricular Systolic Function in Patients with Atrial Fibrillation and Preserved Kidney Function: Analysis of the POL-AF Registry Cohort
por: Wełnicki, Marcin, et al.
Publicado: (2022)

Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry
por: Gawałko, Monika, et al.
Publicado: (2021)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?—Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Szyszkowska, Anna, et al.
Publicado: (2022)

Elective cardioversion of atrial fibrillation is safe without transesophageal echocardiography in patients treated with non-vitamin K antagonist oral anticoagulants: Multicenter experience
por: Gorczyca, Iwona, et al.
Publicado: (2023)

Left Atrial Appendage Thrombus Formation Despite Continuous Non-Vitamin K Antagonist Oral Anticoagulant Therapy in Atrial Fibrillation Patients Undergoing Electrical Cardioversion or Catheter Ablation: A Comparison of Dabigatran and Rivaroxaban
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Left Ventricular Ejection Fraction Is Associated with the Risk of Thrombus in the Left Atrial Appendage in Patients with Atrial Fibrillation
por: Uziębło-Życzkowska, Beata, et al.
Publicado: (2020)

Risk of left atrial appendage thrombus in patients with atrial fibrillation and chronic kidney disease
por: Budnik, Monika, et al.
Publicado: (2022)

Risk of left atrial appendage thrombus in older patients with atrial fibrillation
por: Gawałko, Monika, et al.
Publicado: (2021)

Does the CHA(2)DS(2)-VASc scale sufficiently predict the risk of left atrial appendage thrombus in patients with diagnosed atrial fibrillation treated with non-vitamin K oral anticoagulants?
por: Michalska, Anna, et al.
Publicado: (2020)

Is transesophageal echocardiography necessary before electrical cardioversion in patients treated with non-vitamin K antagonist oral anticoagulants? Current evidence and practical approach
por: Gorczyca, Iwona, et al.
Publicado: (2023)

Associations between Heart Rate Variability Parameters and Hemodynamic Profiles in Patients with Primary Arterial Hypertension, Including Antihypertensive Treatment Effects
por: Maciorowska, Małgorzata, et al.
Publicado: (2022)

Increased Body Mass Index and Risk of Left Atrial Thrombus in Nonvalvular Atrial Fibrillation Patients—Data from the Left Atrial Thrombus on Transesophageal Echocardiography (LATTEE) Registry
por: Uziębło-Życzkowska, Beata, et al.
Publicado: (2022)

Risk factors for left atrial thrombus in younger patients (aged < 65 years) with atrial fibrillation or atrial flutter: Data from the multicenter left atrial thrombus on transesophageal echocardiography (LATTEE) registry
por: Uziȩbło-Życzkowska, Beata, et al.
Publicado: (2022)

Echocardiographic predictors of thrombus in left atrial appendage—The role of novel transthoracic parameters
por: Kaufmann, Damian, et al.
Publicado: (2022)

The Importance of a Distance between the Lines Encircling Pulmonary Veins in Atrial Fibrillation Ablation on First-Pass Isolation Ratio and Clinical Outcomes
por: Krzyżanowski, Krystian, et al.
Publicado: (2023)

Value of Left Atrial Strain in Predicting Recurrence after Atrial Fibrillation Ablation
por: Kiliszek, Marek, et al.
Publicado: (2023)

Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation: A real-world experience
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in secondary stroke and systemic embolism prevention
por: Gorczyca, Iwona, et al.
Publicado: (2019)

Myocarditis successfully diagnosed and controlled with speckle tracking echocardiography
por: Uziębło-Życzkowska, Beata, et al.
Publicado: (2020)

Haemodynamic Effects of Anaemia in Patients with Acute Decompensated Heart Failure
por: Krzesiński, Paweł, et al.
Publicado: (2020)

Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter
por: Wybraniec, Maciej T., et al.
Publicado: (2022)

Cushing’s Disease: Assessment of Early Cardiovascular Hemodynamic Dysfunction With Impedance Cardiography
por: Jurek, Agnieszka, et al.
Publicado: (2021)

Acromegaly: The Research and Practical Value of Noninvasive Hemodynamic Assessments via Impedance Cardiography
por: Jurek, Agnieszka, et al.
Publicado: (2022)

Increased Thoracic Fluid as the Most Distinctive Cardiovascular Hemodynamic Alteration in Men with Prolactinoma
por: Jurek, Agnieszka, et al.
Publicado: (2022)

The patient’s sex determines the hemodynamic profile in patients with Cushing disease
por: Jurek, Agnieszka, et al.
Publicado: (2023)

Left Atrial Thrombus in Atrial Fibrillation/Flutter Patients in Relation to Anticoagulation Strategy: LATTEE Registry
por: Kapłon-Cieślicka, Agnieszka, et al.
Publicado: (2022)

New oral anticoagulants – will they be used with antiplatelet drugs in patients with atrial fibrillation after acute coronary syndrome?
por: Gorczyca-Michta, Iwona, et al.
Publicado: (2013)

Association of Central Sleep Apnea with Impaired Heart Structure and Cardiovascular Hemodynamics in Patients with Chronic Heart Failure
por: Kazimierczak, Anna, et al.
Publicado: (2016)

Left Heart Dysfunction in Acromegaly Revealed by Novel Echocardiographic Methods
por: Uziȩbło-Życzkowska, Beata, et al.
Publicado: (2020)

Periodontal disease in relation to selected parameters of the cardiovascular system in a group of patients with stable angina pectoris
por: Włosowicz, Monika, et al.
Publicado: (2014)

Trends in Stroke Prevention between 2014 and 2018 in Hospitalized Atrial Fibrillation Patients
por: Bielecka, B., et al.
Publicado: (2021)

Pharmacotherapy of atrial fibrillation in COVID-19 patients
por: Tomaszuk-Kazberuk, Anna, et al.
Publicado: (2021)

Nine-Year Trends in Prevention of Thromboembolic Complications in Elderly Patients with Atrial Fibrillation Treated with NOACs
por: Bielecka, Bernadetta, et al.
Publicado: (2022)

Temporal Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients between 2004 and 2019
por: Gorczyca-Głowacka, Iwona, et al.
Publicado: (2022)

Persistent atrial fibrillation is not associated with thrombomodulin level increase in efficiently anticoagulated patients
por: Wożakowska-Kapłon, Beata, et al.
Publicado: (2010)

Left atrial emptying fraction determined during atrial fibrillation predicts maintenance of sinus rhythm after direct current cardioversion in patients with persistent atrial fibrillation
por: Wałek, Paweł, et al.
Publicado: (2020)

Left atrial wall dyskinesia assessed during contractile phase as a predictor of atrial fibrillation recurrence after electrical cardioversion performed due to persistent atrial fibrillation
por: Wałek, Paweł, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kbtkt0ili1ujv8ec4qmbga19h7